As the second Trump administration settles in, the U.S.' top pharmaceutical trade group is drafting its ambitions for the ...

PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...

The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

A new report from industry trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has shed a new light ...

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. John C. Reed, MD, PhD, Executive Vice President of Innovative Medicine R&D at Johnson & Johnson (J&J), and Dr. Donatello ...

President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.

The pharmaceutical industry is framing itself as a key partner for President Trump and HHS Secretary Robert F. Kennedy Jr. in ...

Calls continue to reduce the price of prescription drugs in Illinois. Hundreds of Illinoisans descended on the Illinois State House Tuesday calling for legislation to control the rising costs of ...

Viewers of the Super Bowl may have seen an ad from one of the largest compounders in the United States, Hims & Hers, promoting… ...

Several top lobbying names on Washington, D.C.'s K Street, who have voiced opposition to President Donald Trump in the past, ...

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...